(Q79185026)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568003%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

Intervention against the Maillard reaction in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568003%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568003

23 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

23 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

23 March 2024

Vincent M. Monnier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568003

23 March 2024

language of work or name

English

0 references

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568003%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 December 2019

https://api.elsevier.com/content/article/PII:S0003986103004363?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

https://api.elsevier.com/content/article/PII:S0003986103004363?httpAccept=text/plain

23 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

23 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568003%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

419

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568003%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568003%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

1-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568003%20AND%20SRC:MED&resulttype=core&format=json

Dehydrated Foods, Chemistry of Browning Reactions in Model Systems

20 December 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

23 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Glycation products and the pathogenesis of diabetic complications

23 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

23 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Mechanisms of maturation and ageing of collagen

23 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

23 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen.

23 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

23 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Longitudinal determination of skin collagen glycation and glycoxidation rates predicts early death in C57BL/6NNIA mice.

23 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Relationship between mechanical properties and pentosidine in tendon: effects of age, diet restriction, and aminoguanidine in broiler breeder hens

23 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

The effect of caloric restriction on glycation and glycoxidation in skin collagen of nonhuman primates

23 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Differential effects of type 2 (non-insulin-dependent) diabetes mellitus on pentosidine formation in skin and glomerular basement membrane

23 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Mortality and morbidity in laboratory-maintained Rhesus monkeys and effects of long-term dietary restriction

23 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S

23 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

23 March 2024

21

Metz

2003

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

A New Mechanism of the Maillard Reaction Involving Sugar Fragmentation and Free Radical Formation

23 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose

23 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Use of ascorbate as test for catalytic metals in simple buffers

23 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate

23 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Detection of alpha-dicarbonyl compounds in Maillard reaction systems and in vivo

23 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions

23 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product

23 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Peroxynitrite induces formation of N( epsilon )-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite.

23 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes

23 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Protein Aging by Carboxymethylation of Lysines Generates Sites for Divalent Metal and Redox Active Copper Binding: Relevance to Diseases of Glycoxidative Stress

23 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents

23 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo

23 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Chelating activity of advanced glycation end-product inhibitors

23 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

23 March 2024

39

Figarola

2003

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

23 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Vitamin C metabolomic mapping in experimental diabetes with 6-deoxy-6-fluoro-ascorbic acid and high resolution 19F-nuclear magnetic resonance spectroscopy

23 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence

23 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis.

23 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Ageing promotes the increase of early glycation Amadori product as assessed by epsilon-N-(2-furoylmethyl)-L-lysine (furosine) levels in rodent skin collagen. The relationship to dietary restriction and glycoxidation

23 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Site-specific quantitative evaluation of the protein glycation product N6-(2,3-dihydroxy-5,6-dioxohexyl)-L-lysinate by LC-(ESI)MS peptide mapping: evidence for its key role in AGE formation

23 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication

23 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Synthesis of 1-deoxy-D-erythro-hexo-2,3-diulose, a major hexose Maillard intermediate.

23 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline

23 March 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Amides are novel protein modifications formed by physiological sugars

23 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Crosslines A and B as candidates for the fluorophores in age- and diabetes- related cross-linked proteins, and the diacetates produced by Maillard reaction of a-N-acetyl-L-lysine with D-glucose.

23 March 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Identification and quantification of major maillard cross-links in human serum albumin and lens protein. Evidence for glucosepane as the dominant compound

23 March 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Formation pathways for lysine-arginine cross-links derived from hexoses and pentoses by Maillard processes: unraveling the structure of a pentosidine precursor

23 March 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Non-enzymatic glycosylation and the chronic complications of diabetes: an overview

23 March 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats

23 March 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

23 March 2024

60

Cohen

2003

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse

23 March 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Receptors specific for Amadori-modified glycated albumin on murine endothelial cells

23 March 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Evidence for binding of in vitro glycated low-density lipoproteins by fructosyllysine-specific sites on macrophages and U937 monocyte-like cells

23 March 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

23 March 2024

64

Wu

2003

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase

23 March 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo

23 March 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes

23 March 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

The glyoxalase system in health and disease

23 March 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Semicarbazide-sensitive amine oxidase in aortic smooth muscle cells mediates synthesis of a methylglyoxal-AGE: implications for vascular complications in diabetes

23 March 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Iron (II) Ions Induced Oxidation of Ascorbic Acid and Glucose

23 March 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

23 March 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence

23 March 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Accumulation of alpha-oxoaldehydes during oxidative stress: a role in cytotoxicity

23 March 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats

23 March 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Correlations between DNA and cytogenetic damage induced after chemical treatment and radiation

23 March 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

23 March 2024

80

Thornalley

2003

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Mechanisms for the formation of glycoxidation products in end-stage renal disease

23 March 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction

23 March 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Physiological and pathological implications of semicarbazide-sensitive amine oxidase

23 March 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Effect of pyridoxamine on semicarbazide-sensitive amine oxidase activity of rabbit lung and heart.

23 March 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy

23 March 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Scavenger receptors that recognize advanced glycation end products

23 March 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

The AGE-receptor in the pathogenesis of diabetic complications

23 March 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

23 March 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif.

23 March 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix

23 March 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat

23 March 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

23 March 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Biochemistry and molecular cell biology of diabetic complications

23 March 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

23 March 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Aging is associated with a decrease in synaptosomal glutamate uptake and an increase in the susceptibility of synaptosomal vitamin E to oxidative stress.

23 March 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

23 March 2024

100

Vasan

2003

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Suppression of pentosidine formation in galactosemic rat lens by an inhibitor of aldose reductase

23 March 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Journal of Biological Chemistry

23 March 2024

103

Culbertson

2003

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy

23 March 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Lilly Lecture 1993. Glycation and diabetic complications

23 March 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

23 March 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine

23 March 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

23 March 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

23 March 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Oxidative DNA damage induced by high glucose and its suppression in human umbilical vein endothelial cells

23 March 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage

23 March 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation

23 March 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.

23 March 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Carbonyl compounds cross-link cellular proteins and activate protein-tyrosine kinase p60c-Src

23 March 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195

23 March 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

23 March 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Inhibitor for advanced glycation end products formation attenuates hypertension and oxidative damage in genetic hypertensive rats

23 March 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms

23 March 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Carbonyl Stress and Diabetic Complications

23 March 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes

23 March 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

23 March 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

23 March 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats

23 March 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide

23 March 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Inhibitory effects of tenilsetam on the Maillard reaction

23 March 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Glycation of human serum albumin: inhibition by Diclofenac

23 March 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Ageing of the human corneal stroma: structural and biochemical changes

23 March 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Vitamins and analgesics in the prevention of collagen ageing

23 March 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

The inhibition of sugar-induced structural alterations in collagen by aspirin and other compounds

23 March 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM

23 March 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Glycation-induced inactivation of malate dehydrogenase protection by aspirin and a lens molecular chaperone, alpha-crystallin

23 March 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

The non-enzymic glycosylation of bovine lens proteins by glucosamine and its inhibition by aspirin, ibuprofen and glutathione

23 March 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Non-enzymic glycosylation (glycation) of lens proteins by galactose and protection by aspirin and reduced glutathione

23 March 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

The polyamines spermine and spermidine protect proteins from structural and functional damage by AGE precursors: a new role for old molecules?

23 March 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

23 March 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.

23 March 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Anti-Hypertensive Agents Inhibit In Vivo the Formation of Advanced Glycation End Products and Improve Renal Damage in a Type 2 Diabetic Nephropathy Rat Model

23 March 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Purification of histaminase (diamine oxidase) from human pregnancy plasma by affinity chromatography

23 March 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Pyridoxamine as inhibitor of the blood plasma benzylamine oxidase and other copper-containing amine oxidases

23 March 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Metformin reduces systemic methylglyoxal levels in type 2 diabetes

23 March 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats

23 March 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation

23 March 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Effects of Metformin on Collagen Glycation and Diastolic Dysfunction in Diabetic Myocardium

23 March 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions

23 March 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose

23 March 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations

23 March 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats

23 March 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy

23 March 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Evaluation of the effect of aldose reductase inhibition on increased basement membrane collagen fluorescence in diabetic rats

23 March 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients

23 March 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway

23 March 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat

23 March 2024

161

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

L-carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities

23 March 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Efficacy of N-acetylcarnosine in the treatment of cataracts

23 March 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Carnosine protects proteins against methylglyoxal-mediated modifications.

23 March 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Carnosine promotes the heat denaturation of glycated protein.

23 March 2024

165

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Detoxification of cytotoxic alpha,beta-unsaturated aldehydes by carnosine: characterization of conjugated adducts by electrospray ionization tandem mass spectrometry and detection by liquid chromatography/mass spectrometry in rat skeletal muscle.

23 March 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Carnosine is a quencher of 4-hydroxy-nonenal: through what mechanism of reaction?

23 March 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

The botanical extracts of Achyrocline satureoides and Ilex paraguariensis prevent methylglyoxal-induced inhibition of plasminogen and antithrombin III.

23 March 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Protein glycation inhibitors from thyme (Thymus vulgaris)

23 March 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Chemical studies on antioxidant mechanism of curcuminoid: analysis of radical reaction products from curcumin

23 March 2024

170

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Chemical studies on antioxidant mechanism of curcumin: analysis of oxidative coupling products from curcumin and linoleate

23 March 2024

171

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats

23 March 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Diminished Heme Oxygenase Potentiates Cell Death: Pyrrolidinedithiocarbamate Mediates Oxidative Stress

23 March 2024

174

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin

23 March 2024

175

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro

23 March 2024

176

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation

23 March 2024

177

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

L-lysine reduces nonenzymatic glycation of glomerular basement membrane collagen and albuminuria in diabetic rats

23 March 2024

178

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Effect of alpha-glucosidase inhibition on the nonenzymatic glycation of glomerular basement membrane

23 March 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Alpha-glucosidase inhibition prevents increased collagen fluorescence in experimental diabetes

23 March 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

Advanced glycation end product precursors impair epidermal growth factor receptor signaling.

23 March 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.014

23 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568003%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference